Skip to main content
Clinical Trials/NCT01979068
NCT01979068
Completed
Not Applicable

Vascular Inflammation Stratified by Body Size Phenotype

Korea University1 site in 1 country250 target enrollmentMarch 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atherosclerosis
Sponsor
Korea University
Enrollment
250
Locations
1
Primary Endpoint
max TBR values stratified by the four body size phenotypes
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

  • Vascular Inflammation is a key factor in both the pathogenesis and outcome of atherosclerosis. 18FDG-PET is a promising novel tool for identifying and quantifying vascular inflammation within atherosclerotic plaque
  • Recently, unique subsets of obese individuals, such as metabolically obese but normal weight (MONW) and metabolically healthy obese (MHO), have been getting an attention
  • Therefore, the purpose of this study is to examine the relationship of vascular inflammation,measured by FDG-PET, with various body sized phenotypes
Registry
clinicaltrials.gov
Start Date
March 2008
End Date
March 2011
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

K. M. Choi

Professor

Korea University

Eligibility Criteria

Inclusion Criteria

  • Healthy patients for visiting routine medical check in our clinic

Exclusion Criteria

  • history of CVD (myocardial infarction, unstable angina, stroke, or cardiovascular revascularization)
  • stage 2 hypertension (resting blood pressure, ≥160/100 mmHg)
  • history of inflammatory conditions that affect the study results
  • taking medications that might affect inflammatory status, including steroid and non-steroidal anti-inflammatory drug within 6 months
  • or malignancy or severe renal or hepatic disease

Outcomes

Primary Outcomes

max TBR values stratified by the four body size phenotypes

Time Frame: 12 weeks

Secondary Outcomes

  • Framingham risk scores according to the four body size phenotypes(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials